XML 18 R7.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Consolidated Condensed Statements of Shareholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-In Capital
Retained Earnings
Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Sep. 30, 2022   6,040      
Beginning balance at Sep. 30, 2022 $ 40,690 $ 6,040 $ 11,387 $ 31,956 $ (8,693)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Comprehensive (loss) income (4,387)     (4,956) 569
Performance and restricted share expense 207   207    
Share transactions under equity-based plans (in shares)   68      
Share transactions under equity-based plans (71) $ 68 (139)    
Ending balance (in shares) at Mar. 31, 2023   6,108      
Ending balance at Mar. 31, 2023 36,439 $ 6,108 11,455 27,000 (8,124)
Beginning balance (in shares) at Dec. 31, 2022   6,072      
Beginning balance at Dec. 31, 2022 38,573 $ 6,072 11,406 29,367 (8,272)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Comprehensive (loss) income (2,219)     (2,367) 148
Performance and restricted share expense 85   85    
Share transactions under equity-based plans (in shares)   36      
Share transactions under equity-based plans 0 $ 36 (36)    
Ending balance (in shares) at Mar. 31, 2023   6,108      
Ending balance at Mar. 31, 2023 $ 36,439 $ 6,108 11,455 27,000 (8,124)
Beginning balance (in shares) at Sep. 30, 2023 6,105 6,105      
Beginning balance at Sep. 30, 2023 $ 34,335 $ 6,105 11,626 23,264 (6,660)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Comprehensive (loss) income (4,801)     (5,012) 211
Performance and restricted share expense 171   171    
Share transactions under equity-based plans (in shares)   85      
Share transactions under equity-based plans $ (49) $ 85 (134)    
Ending balance (in shares) at Mar. 31, 2024 6,190 6,190      
Ending balance at Mar. 31, 2024 $ 29,656 $ 6,190 11,663 18,252 (6,449)
Beginning balance (in shares) at Dec. 31, 2023   6,160      
Beginning balance at Dec. 31, 2023 31,247 $ 6,160 11,609 19,842 (6,364)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Comprehensive (loss) income (1,675)     (1,590) (85)
Performance and restricted share expense 84   84    
Share transactions under equity-based plans (in shares)   30      
Share transactions under equity-based plans $ 0 $ 30 (30)    
Ending balance (in shares) at Mar. 31, 2024 6,190 6,190      
Ending balance at Mar. 31, 2024 $ 29,656 $ 6,190 $ 11,663 $ 18,252 $ (6,449)